Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated Vasculitis

INTRODUCTION: The value of antineutrophil cytoplasmic antibody (ANCA) measurements among patients with an established diagnosis of ANCA-associated vasculitis (AAV) to assess disease activity or predict relapse remains controversial, but recent evidence suggests a possible role for rituximab-treated...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Rheumatol
Huvudupphovsmän: McClure, Mark E., Wason, James, Gopaluni, Seerapani, Tieu, Joanna, Smith, Rona M., Jayne, David R., Jones, Rachel B.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7612177/
https://ncbi.nlm.nih.gov/pubmed/30896460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RHU.0000000000001030
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk